Pharmaceutics seminars are open to the public and offered weekly during the academic year.
Tuesdays 3:00 to 4:00 PM CT, Moos 5-125
Email [email protected] to request a Zoom link
January 20
HSWG Formulation and Process Platforms for High Drug-Load Tablets
Tianyi Xiang, PhD Candidate, Sun and Siegel Labs
January 27
Exploiting synthetic lethality for treatment of NF1 associated nervous system tumors
David Largaespada, PhD, Professor, Department of Pediatrics and Department of Genetics, Cell Biology, and Development, and Interim Deputy Director, Masonic Cancer Center, University of Minnesota
February 3
Targeting FGFR Signaling in Glioblastoma: Preclinical Studies with the Pan-FGFR Inhibitor Futibatinib
Ruisi Leng, PhD Student, Elmquist Lab
February 10
Peptide targeting to improve the delivery and therapeutic efficacy of glucocorticoids
Mitch Kowalke, PhD Candidate, Pang Lab
February 17
The effect of Amyloid beta exposure on PDGF-BB: PDGFRβ signaling in the neurovascular unit
Vineetha Guttha, PhD Student, Kandimalla Lab
Targeting novel inhibitors of the MAPK pathway for gliomas
Prachi Shrivastav, PhD Student, Elmquist Lab
February 24
Role of Collagen-Integrin Signaling in Neurovascular Dysfunction in Alzheimer's Disease
Lyle Nyberg, PhD Student, Kandimalla Lab
A Brain-Penetrant Molecular Glue to Inhibit MAPK Signaling
Aran Kim, PhD Student, Elmquist Lab
March 3
The Lived Experience of Women in Science
Carolyn Fairbanks, PhD, Professor, Department of Pharmaceutics, and Associate Dean for Research, College of Pharmacy, University of Minnesota
March 10
No Seminar - Spring Break
March 17
Development of Agmatine Analogs for Improved Analgesia
Riddhi Kini, PhD Candidate, Fairbanks Lab
Dysregulation of Angiopoietin Signaling Aggravates Cerebrovascular Pathology in Alzheimer’s Disease
Muskan Badola, PhD Student, Kandimalla Lab
March 24
p53 dynamics and the response to DNA damage in single cells
Eric Batchelor, PhD, Assistant Professor, Department of Integrative Biology and Physiology, University of Minnesota Medical School
March 31
Peptide-guided delivery for novel biology and therapies
Hongbo Pang, PhD, Associate Professor, Department of Pharmaceutics
April 7
Artificial Intelligence Applications in Pharmacometrics and Clinical Pharmacology
Murali Ramanathan, PhD, Professor, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
April 14
TXNIP in Alzheimer’s Disease: A Multi-Pronged Regulator of Oxidative Stress, Inflammation, and Membrane Trafficking
Zheng Xue, PhD Student, Kandimalla Lab
Engineering Nanoparticles for Targeted Nucleic Acid Delivery to Brain Endothelial Cells in Alzheimer’s Disease
Marina Ruleva, PhD Student, Siegel and Kandimalla Labs
April 21
From Self-Assembled Hydrogels to Multi-Antigen T Cell Hybridizers
Jindřich Henry Kopeček, PhD, DSc, Distinguished Professor of Biomedical Engineering, Distinguished Professor of Molecular Pharmaceutics, Director, Center for Controlled Chemical Delivery, Center for Controlled Chemical Delivery, University of Utah
April 28
Antibodies and the BBB: Will it Work for GBMs?
Anya Benson, PhD Student, Elmquist Lab
Identification of Novel Therapeutics to Target Reactive Oxygen Species
Indy Hauter, PhD Student, Kirtane Lab